Millennium Management’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,751,857
| Closed | -$25.2M | – | 7588 |
|
|
2021
Q2 | $25.2M | Buy |
2,751,857
+2,728,735
| +11,801% | +$15.9M | 0.02% | 1012 |
|
|
2021
Q1 | $115K | Sell |
23,122
-57,922
| -71% | -$280K | ﹤0.01% | 5668 |
|
|
2020
Q4 | $349K | Buy |
81,044
+12,481
| +18% | +$50.8K | ﹤0.01% | 4461 |
|
|
2020
Q3 | $294 | Sell |
68,563
-753,189
| -92% | -$3.15M | ﹤0.01% | 3855 |
|
|
2020
Q2 | $3.69M | Buy |
+821,752
| New | +$3.67M | 0.01% | 2039 |
|
|
2020
Q1 | – | Sell |
-47,303
| Closed | -$401K | – | 4777 |
|
|
2019
Q4 | $401K | Sell |
47,303
-13,141
| -22% | -$103K | ﹤0.01% | 3507 |
|
|
2019
Q3 | $414K | Sell |
60,444
-122,721
| -67% | -$900K | ﹤0.01% | 3376 |
|
|
2019
Q2 | $1.53M | Sell |
183,165
-89,382
| -33% | -$771K | ﹤0.01% | 2566 |
|
|
2019
Q1 | $2.5M | Buy |
+272,547
| New | +$2.77M | ﹤0.01% | 2261 |
|
|
2018
Q4 | – | Sell |
-11,653
| Closed | -$163K | – | 4367 |
|
|
2018
Q3 | $163K | Buy |
+11,653
| New | +$158K | ﹤0.01% | 3674 |
|
|
2018
Q1 | – | Sell |
-13,400
| Closed | -$127K | – | 4242 |
|
|
2017
Q4 | $127K | Sell |
13,400
-2,180
| -14% | -$17K | ﹤0.01% | 3622 |
|
|
2017
Q3 | $122K | Sell |
15,580
-38,506
| -71% | -$289K | ﹤0.01% | 3340 |
|
|
2017
Q2 | $465K | Sell |
54,086
-38,456
| -42% | -$276K | ﹤0.01% | 2835 |
|
|
2017
Q1 | $652K | Buy |
92,542
+80,815
| +689% | +$506K | ﹤0.01% | 2649 |
|
|
2016
Q4 | $50K | Buy |
+11,727
| New | +$56.8K | ﹤0.01% | 3251 |
|
|
2015
Q4 | – | Sell |
-48,270
| Closed | -$251K | – | 3894 |
|
|
2015
Q3 | $251K | Sell |
48,270
-7,340
| -13% | -$45.3K | ﹤0.01% | 3008 |
|
|
2015
Q2 | $379K | Buy |
55,610
+26,804
| +93% | +$190K | ﹤0.01% | 2769 |
|
|
2015
Q1 | $206K | Sell |
28,806
-21,834
| -43% | -$150K | ﹤0.01% | 3289 |
|
|
2014
Q4 | $377K | Buy |
50,640
+25,465
| +101% | +$216K | ﹤0.01% | 3200 |
|
|
2014
Q3 | $233K | Buy |
+25,175
| New | +$340K | ﹤0.01% | 3297 |
|
Other funds holding KIN
Millennium Management's KIN Position: Q3 2021 in Review
Millennium Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 2,751,857 shares — an estimated $25.2M sold.
Millennium Management first reported a position in KIN in Q3 2014 and held it in 20 quarters. The position peaked at $25.2M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Millennium Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Millennium Management sold 2,751,857 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $25.2M.
- Millennium Management first reported a position in Kindred Biosciences, Inc. in Q3 2014 and held it in 20 quarters.
- Millennium Management's Kindred Biosciences, Inc. position peaked at $25.2M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.